BAŞ, O. Et Al. 2022. Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis. SUPPORTIVE CARE IN CANCER , vol.30, no.11 , 9071-9078.

BAŞ, O., Erul, E., GÜVEN, D. C., & AKSOY, S., (2022). Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis. SUPPORTIVE CARE IN CANCER , vol.30, no.11, 9071-9078.

BAŞ, ONUR Et Al. "Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis," SUPPORTIVE CARE IN CANCER , vol.30, no.11, 9071-9078, 2022

BAŞ, ONUR Et Al. "Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis." SUPPORTIVE CARE IN CANCER , vol.30, no.11, pp.9071-9078, 2022

BAŞ, O. Et Al. (2022) . "Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis." SUPPORTIVE CARE IN CANCER , vol.30, no.11, pp.9071-9078.

@article{article, author={ONUR BAŞ Et Al. }, title={Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis}, journal={SUPPORTIVE CARE IN CANCER}, year=2022, pages={9071-9078} }